Therapeutic Approaches to the Alternative Angiotensin-(1-7) Axis of the Renin-Angiotensin System

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Hypertension Research

Background:

• Cardiovascular disease (CVD) remains a primary cause of mortality in the US.
• The renin-angiotensin system (RAS) is vital for regulating blood pressure and fluid balance.
• Current treatments often target the Ang II-AT1 receptor axis within the RAS.

Purpose of the Study:

• To review the role of the RAS in cardiovascular disease and hypertension.
• To discuss established pharmacologic strategies targeting the RAS.
• To highlight the Ang II-AT1 receptor axis as a key therapeutic target.

Main Methods:

• Literature review of cardiovascular disease and RAS.
• Analysis of pharmacologic approaches for RAS inhibition.
• Examination of angiotensin converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARBs).

Main Results:

• The RAS plays a critical role in blood pressure regulation and cardiovascular pathology.
• ACE inhibitors prevent Ang II generation, while ARBs block Ang II binding to AT1 receptors.
• Both ACEI and ARBs are established treatments for hypertension and related cardiovascular conditions.

Conclusions:

• Targeting the RAS, particularly the Ang II-AT1 receptor axis, is a cornerstone of cardiovascular disease and hypertension management.
• Pharmacologic interventions like ACE inhibitors and ARBs effectively modulate the RAS.
• Continued research into RAS modulation holds promise for improving cardiovascular outcomes.